PSNResearch
Private Company
Funding information not available
Overview
Founded in 2015, PSNResearch is a private, revenue-generating clinical research organization (CRO) and services provider headquartered in Barcelona. The company provides comprehensive clinical development services with a strong focus on complex areas like advanced therapies (ATMPs), orphan drugs, neurology, and immuno-oncology. It operates by building unique partnerships for senior-level collaboration, guiding sponsors through regulatory processes, and managing trials from first-in-human to post-marketing. While not developing its own therapeutics, PSNResearch's model is built on deep therapeutic and regulatory expertise to de-risk and accelerate client programs.
Technology Platform
Integrated clinical development services platform with expertise in regulatory strategy (EMA/FDA/CTIS), clinical trial management, biometrics/big data, and specialized support for Advanced Therapies (ATMPs) and orphan drugs. No proprietary therapeutic technology.
Opportunities
Risk Factors
Competitive Landscape
PSNResearch competes in the fragmented global CRO market. It differentiates itself from large players (e.g., IQVIA, ICON) by offering senior-level, hands-on partnership and deep niche expertise in advanced therapies and complex trials. It faces competition from other specialized, mid-sized CROs focusing on similar therapeutic areas and service models in Europe.